Interstitial lung disease and pulmonary arterial hypertension are the main causes of mortality and morbidity in patients with collagen vascular disease.

Drugs used to treat rheumatoid arthritis, such as gold salts and penicillamine, may cause diffuse alveolar damage or obliterative bronchiolitis.